| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 117.324 | 211.714 | 274.426 | 471.260 |
| Total Income - EUR | - | - | - | - | - | - | 117.537 | 212.130 | 274.859 | 471.379 |
| Total Expenses - EUR | - | - | - | - | - | - | 94.464 | 172.883 | 232.606 | 409.317 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 23.073 | 39.247 | 42.253 | 62.062 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 21.898 | 37.172 | 39.727 | 48.912 |
| Employees | - | - | - | - | - | - | 13 | 21 | 25 | 38 |
Check the financial reports for the company - Enb Anmima Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 10.640 | 16.050 | 25.731 | 33.455 |
| Current Assets | - | - | - | - | - | - | 41.927 | 54.815 | 81.307 | 135.059 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 30.862 | 24.133 | 71.587 | 114.407 |
| Cash | - | - | - | - | - | - | 11.065 | 30.682 | 9.720 | 20.652 |
| Shareholders Funds | - | - | - | - | - | - | 21.938 | 37.221 | 39.779 | 48.964 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 30.628 | 33.645 | 67.258 | 119.831 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Enb Anmima Intermed S.r.l.